Changes in cardiac biomarkers with bortezomib treatment in patients with advanced cardiac amyloidosis

Antzeko izenburuak

• Monocyte recovery at day 100 is associated with improved survival in multiple myeloma patients who undergo allogeneic hematopoietic cell transplantation
  nork: Dhakal, Binod, et al.
  Argitaratua: (2015)
• Recent advances in understanding and treating immunoglobulin light chain amyloidosis
  nork: Badar, Talha, et al.
  Argitaratua: (2018)
• Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis
  nork: D'Souza, Anita, et al.
  Argitaratua: (2017)
• Baseline patient-reported outcomes in light chain amyloidosis patients enrolled on an interventional clinical trial
  nork: D’Souza, Anita, et al.
  Argitaratua: (2019)
• Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004–2014
  nork: D’Souza, Anita, et al.
  Argitaratua: (2017)